GET IN EARLY & BE A PART OF GENECRYPT
Globally the genomics market is increasing by approximately 19% CAGR. Within seven years the Precision Medicine market is estimated be worth approx USD $176 billion. We aim to provide the infrastructure that supports the industry.
GeneCrypt is opening an investment round now. Apply below to be part of our story as an investor. We would be delighted to arrange an introductory meeting and run through of our pitch deck.
GeneCrypt technology provides the base layer core technology for the genomics industry. As such there are multiple opportunities for strategic partnerships and joint ventures with Precision Medicine and Research organizations. Please contact us if you’d like to discuss potential synergies.